Catherine Coste

Catherine Coste

Director/Board Member at RENALYTIX PLC

Net worth: 393 453 $ as of 31/05/2026

60 year
Health Technology
Commercial Services
Consumer Services

Profile

Catherine Havlik Coste is currently an Independent Non-Executive Director at Renalytix Plc since 2023 and an Independent Director at BioLife Solutions, Inc. starting in 2025.
Formerly, Ms. Coste was an Independent Director at Biomerica, Inc. from 2020 to 2025, an Independent Director at Minerva Surgical, Inc. from 2021 to 2025, and a Senior Partner at Deloitte & Touche LLP from 1988 to 2020.
Education includes undergraduate studies at California State University-East Bay.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
24/02/2026 13,871 ( 0.03% ) 345 665 $ 31/05/2026
13/12/2024 16,099 ( 0.52% ) 38 444 $ 31/05/2026
22/09/2025 385,129 ( 0.09% ) 9 343 $ 31/05/2026

Catherine Coste active positions

CompaniesPositionStart
RENALYTIX PLC Director/Board Member 30/06/2023
BIOLIFE SOLUTIONS, INC. Director/Board Member 18/03/2025

Former positions of Catherine Coste

CompaniesPositionEnd
BIOMERICA, INC. Director/Board Member 04/06/2025
MINERVA SURGICAL, INC. Director/Board Member 01/05/2025
Corporate Officer/Principal 01/09/2020
See the detail of Catherine Coste's experience

Training of Catherine Coste

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Catherine Coste